Health Condition 1: N461- Oligospermia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age From 21 Years to 40 Years Male. 2. No history of serious illness or disease. 3. Not under any type of medical treatment since last six months. 4. Subjects having sperm count 05 to 15 million per ml. 5. Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plans. 7. Subjects willing to participate and able to give written informed consent.
Exclusion criteria
Exclusion criteria: Patients having medical history of- a)Men with a total sperm count of 20 million/mL. b)Patients having a history of congenital deformity in genitals. c)Patients with evidence of Malignancy. d)Patients having any type of surgery of genitals. e)Known case of Hypertension, Diabetes Mellitus, Thyroid Dysfunction. f)Patient having any sexual transmitted diseases. g)Patients on prolonged medication with corticosteroids, antidepressants, anticholinergics, immunosuppressant, etc. or any other drugs that may have an influence on the outcome of the study. h)Patients with poorly controlled hypertension (systolic >140 and diastolic >90 mm of Hg) despite of antihypertensive agents. i)Patients who have completed participation in any other clinical trial drugs or their ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Expected Primary End point is improvement in the sperm count from baseline (Day 0) after 90 days of therapy.Timepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| The Expected secondary outcome is the safety and efficacy of the therapy under investigation. Safety will be assessed based on the adverse events recorded during the study.Timepoint: 90 days | — |
Countries
India
Contacts
A and U Tibbia College and Hospital karol bagh